A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cholangiocarcinoma
- Gastrointestinal Neoplasms
- Pancreatic Neoplasms
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Single Group AssignmentIntervention Model Description: Phase Ia: Dose escalation (non randomised, 1 arm) Phase Ib: Dose expansion (randomised, 4 arms)Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04137289
- Collaborators
- Not Provided
- Investigators
- Not Provided